Search

everythinglearnresearchcommunity

for

Search:↓

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

GnRH treatment can reduce breast cancer cell invasion.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

A new model helps predict treatment success in girls with early puberty.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.